IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.377
EU - Europa 9.857
AS - Asia 3.783
AF - Africa 27
SA - Sud America 23
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 20
Totale 32.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.325
PL - Polonia 3.882
CN - Cina 2.565
UA - Ucraina 2.065
DE - Germania 1.167
IT - Italia 889
HK - Hong Kong 652
FI - Finlandia 532
GB - Regno Unito 457
IE - Irlanda 362
IN - India 202
VN - Vietnam 186
FR - Francia 185
RU - Federazione Russa 76
SE - Svezia 71
ES - Italia 59
TR - Turchia 43
CA - Canada 41
BE - Belgio 38
SG - Singapore 38
IR - Iran 33
NL - Olanda 29
AU - Australia 19
EU - Europa 19
MU - Mauritius 16
JP - Giappone 13
CL - Cile 8
CU - Cuba 7
RO - Romania 7
TW - Taiwan 7
MA - Marocco 6
CZ - Repubblica Ceca 5
PE - Perù 5
PH - Filippine 5
AR - Argentina 4
BD - Bangladesh 4
BR - Brasile 4
CH - Svizzera 4
IL - Israele 4
KR - Corea 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AL - Albania 2
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
KG - Kirghizistan 2
LV - Lettonia 2
MX - Messico 2
MY - Malesia 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
PA - Panama 1
SC - Seychelles 1
SL - Sierra Leone 1
SM - San Marino 1
TH - Thailandia 1
Totale 32.109
Salva come PNG Salva come JPEG
Città #
Warsaw 3.882
Fairfield 3.026
Woodbridge 2.187
Jacksonville 1.579
Houston 1.481
Ashburn 1.450
Ann Arbor 1.179
Cambridge 1.173
Seattle 1.076
Wilmington 1.059
Chandler 797
Princeton 669
Hong Kong 646
Nanjing 579
Beijing 481
Dublin 358
Brescia 356
Dearborn 336
New York 302
Helsinki 256
Dong Ket 181
Nanchang 180
Shenyang 147
Des Moines 144
Hebei 144
Jinan 140
San Diego 130
Changsha 124
Jiaxing 101
Lancaster 100
Tianjin 93
Milan 76
Kunming 70
Shanghai 66
London 61
San Mateo 61
Hangzhou 60
Madrid 54
San Francisco 52
Haikou 48
Verona 48
Ningbo 43
Los Angeles 41
Augusta 40
Lanzhou 39
Zhengzhou 36
Kocaeli 35
Rome 35
Leawood 33
Brussels 32
Phoenix 31
Washington 31
Guangzhou 28
Taizhou 28
Boardman 27
Toronto 26
Fuzhou 25
Kilburn 25
Ardabil 24
Norwalk 24
Changchun 23
Monmouth Junction 23
Hefei 21
Taiyuan 19
Redwood City 18
Nürnberg 14
Orange 14
Amsterdam 11
Napoli 11
Padova 11
Pune 11
Gunzenhausen 10
Tokyo 10
Falls Church 9
Chicago 8
Ottawa 8
Wandsworth 8
Chiswick 7
Indiana 7
Ivry-sur-seine 7
La Habana 7
Melbourne 7
Singapore 7
Southwark 7
Canberra 6
Dronten 6
Markham 6
Modena 6
Lima 5
Mumbai 5
New Bedfont 5
New Delhi 5
Sydney 5
Taipei 5
Turin 5
Wuhan 5
Acton 4
Berlin 4
Bologna 4
Bratislava 4
Totale 25.913
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 274
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 263
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 243
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 237
The nanostructured secretome 234
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 231
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 226
Claudin3 is localized outside the tight junctions in human carcinomas 225
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 224
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 224
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 222
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 221
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 220
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 216
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 214
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 211
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 211
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 211
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 210
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 210
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 209
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 208
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 208
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 207
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 203
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 201
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 199
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 198
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 197
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 196
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 195
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 192
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 191
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 187
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 186
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 179
Zebrafish disease models in hematology: Highlights on biological and translational impact 169
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 163
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 159
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 157
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 156
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 151
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 151
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 150
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 150
Long pentraxin-3 follows and modulates bladder cancer progression 149
The zebrafish/tumor xenograft angiogenesis assay. 146
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 145
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 143
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 142
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 142
Anti-angiogenic activity of the purine analog 6-thioguanine. 142
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 138
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 137
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 137
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 137
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 136
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 135
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 134
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 133
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 131
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 129
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 126
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 125
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 123
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 123
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 123
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 122
Heparin octasaccharides inhibit angiogenesis in vivo. 122
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 121
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 120
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 120
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 120
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 119
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 118
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 118
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 116
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 116
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 115
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 115
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 114
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 114
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 114
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 114
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 113
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 113
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 113
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 112
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 112
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 111
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 110
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 110
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. 109
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 109
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 109
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 108
New insights in the modulation of tumor angiogenesis. 108
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 108
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 108
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 107
Totale 15.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.458 0 0 0 0 0 0 0 0 0 588 979 891
2019/202010.258 1.188 416 440 1.166 669 1.174 1.128 1.067 781 1.235 455 539
2020/20216.021 181 641 232 709 324 618 262 687 758 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.383 186 98 337 117 124 466 123 127 680 125 0 0
Totale 32.833